Sie befinden sich hier



European Center for Angioscience

ECAS was founded on December 1st, 2017, the day after its charter was published in the Notes from the Rector of Heidelberg University. Before, the Charter had been approved by the Senate of Heidelberg University.

ECAS is a Center of Heidelberg University that is assigned and allocated to the Medical Faculty Mannheim. The Charter guarantees that ECAS is governed under the auspices and under the supervision of the Dean of the Medical Faculty Mannheim.

The European Center for Angioscience (ECAS) incorporates eight existing professorships from the pre-clinical and clinical-theoretical research areas of the faculty. ECAS will make a plea for three new endowment professorships (Biology of the Vascular Niche and Angiokine Research, Vascular Control of Organ Function, Vascular Control of Metabolism, Vascular Control of Metastasis) which will strengthen the major novel research areas of the European Center for Angioscience.

Medical Faculty Mannheim of Heidelberg University

The Medical Faculty Mannheim of Heidelberg University was founded in 1964 as the second medical faculty of Heidelberg University. The Medical Faculty Mannheim is affiliated with the City of Mannheim Hospital which is run by the City of Mannheim. In 1998, the City of Mannheim Hospital was named City of Mannheim University Hospital, and in 2001, the State of Baden-Württemberg legally guaranteed its status as a University Hospital.

As part of Heidelberg University, the Medical Faculty Mannheim is independent financially and regarding its governing and funding bodies from the affiliated City of Mannheim University Hospital and from the City of Mannheim, and the financial basis of the Medical Faculty Mannheim is economically sound. In addition, the Medical Faculty Mannheim is closely affiliated with the Central Institute of Mental Health Mannheim, the leading psychiatric university hospital and one of the outstanding neuroscience research centers in Germany.

  • Innovative Teaching

    In its early years, the Medical Faculty Mannheim focused primarily on medical education. In 2006, the Medical Faculty Mannheim has developed an innovative teaching curriculum named MaReCuM. MaReCuM has succeeded to establish the Medical Faculty Mannheim among the top 5 faculties in teaching medicine in Germany. The special features of MaReCuM combine early integration of preclinical and clinical aspects and at the same time allow in depth education in areas of choice for the students. Today, the Medical Faculty Mannheim holds the flagship position in medical curriculum development in Germany (MaReCuMplus).

  • Innovative Research

    Similarly, the research performance of the Medical Faculty Mannheim has improved considerably during the last 15 years. In 2014, the Medical Faculty Mannheim received an excellent evaluation by the Council of Science and Humanities (Wissenschaftsrat) of the Federal Republic of Germany which has opened new avenues for research and teaching accomplishments in the near future. The Medical Faculty Mannheim supports four major fields of focus in basic and clinical research, i.e. vascular biology and medicine, medical technology and informatics, oncology, and neuroscience.

    With regard to vascular biology and medicine, the Medical Faculty Mannheim has successfully established a unique and focused basic research agenda in a field of major importance for the aging societies that should be further developed into a flagship of vascular research and therapy in Europe at Heidelberg University.